Gary Friedman

Gary Friedman

Company: Pfizer

Job title: Director, Inflammation & Immunology


Establishing Biomarker Panels to Improve Clinical Trial Design & Optimize Patient Safety 11:00 am

Learn about translational biomarker panel development and proactive communication with regulatory agencies Explore the “Pre-clinical to Clinical Learn-and-Confirm” Paradigm: Prior success to accelerate novel biomarker panel development and implementation Discover the biomarker data repository: sharing anonymized data to benefit patient care globally Examine longitudinal biomarker data sharing and biomarker dynamics in subgroups with and without…Read more

day: Track 1 - Day 1 AM

Panel Discussion: How can we Modernize Surrogate Endpoint Development? Moving Beyond Hard Endpoints 8:00 am

Evaluating novel surrogate endpoints in addition to emerging standard of care Non-invasive imaging, patient-reported outcomes, UACR, and more: what is an acceptable endpoint? Considering payers perspectives’ on moving beyond hard endpoints and ESRDRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.